Human tissue plasminogen activator, purified, glycosylated, 355 residues purified from CHO cells. Retavase is considered a "third-generation" thrombolytic agent, genetically engineered to retain and delete certain portions of human tPA.
This report contains market size and forecasts of Reteplase in global, including the following market information:
Global Reteplase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Reteplase Market Sales, 2017-2022, 2023-2028, (MIU)
Global top five Reteplase companies in 2021 (%)
The global Reteplase market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Reteplase include Angde, Aide Pharmaceutical, Ekr Therapeutics, Reliance Life Sciences, Chiesi Pharmaceuticals Inc. and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Reteplase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Reteplase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Reteplase Market Segment Percentages, by Type, 2021 (%)
Powder
Solution
Global Reteplase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Reteplase Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Reteplase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Reteplase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Reteplase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Reteplase revenues share in global market, 2021 (%)
Key companies Reteplase sales in global market, 2017-2022 (Estimated), (MIU)
Key companies Reteplase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Angde
Aide Pharmaceutical
Ekr Therapeutics
Reliance Life Sciences
Chiesi Pharmaceuticals Inc.
Abbott